Sanofi Dengvaxia Dengue Vaccine from China
Dengvaxia is a live attenuated tetravalent dengue vaccine for seropositive individuals. It is supplied in measured doses for retail sale, qualifying as an immunological product under tariff item 3002.15.00.
Duty Rate — China → Canada
0%
Import Tips
• Confirm that Dengvaxia is approved by Health Canada for import
• Declare the product as an immunological product in measured doses for retail sale
• Keep the cold chain documentation and lot numbers ready for CBSA review